Genistein inhibits bladder cancer cells proliferation by arresting the cell cycle at the G2/M phase via suppression of cyclin A and cyclin B1, and upregulation of CDKN1A (p21/WAF1). Here, CDKN1A is linked to urinary bladder cancer.